Circ‐POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR ‐876‐5p/ FYN axis
Thoracic Cancer · 2024-05 · 15 (13) · 1082-1094
DOI: 10.1111/1759-7714.15273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thoracic Cancer, online erschienen am 29.03.2024. Verfasst von Alan Chu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Circular, Esophageal Neoplasms, Radiation Tolerance. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Joint Construction Project of Medical Science and Technology in Henan Province.
Abstract (Originalsprache)
Background
Circular RNAs (circRNAs) play critical roles in the tumorigenesis and radiosensitivity of multiple cancers. Nevertheless, the biological functions of circRNA periostin (circ‐POSTN) in esophageal cancer (EC) progression and radiosensitivity have not been well elucidated.
Methods
The expression of circ‐POSTN, microRNA‐876‐5p (miR‐876‐5p), and proto‐oncogene tyrosine‐protein kinase (FYN) was analyzed by quantitative reverse transcription PCR (RT‐qPCR). Cell proliferation was assessed by MTT, colony formation, and 5‐ethynyl‐2′‐deoxyuridine (EDU) assays. All protein levels were detected by western blot assay. Cell apoptosis and invasion were assessed by flow cytometry analysis and transwell assay, respectively. Dual‐luciferase reporter and RNA immunoprecipitation (RIP) assays were used to validate the interaction between miR‐876‐5p and circ‐POSTN or FYN. The role of circ‐POSTN in vivo was explored by establishing mice xenograft model.
Results
Circ‐POSTN was overexpressed in EC tissues and cells. Knockdown of circ‐POSTN inhibited cell proliferation and invasion and elevated apoptosis and radiosensitivity in EC cells. MiR‐876‐5p was a direct target of circ‐POSTN, and its knockdown reversed the role of sh‐circ‐POSTN in EC cells. FYN was a direct target of miR‐876‐5p, and FYN elevation weakened the effects of miR‐876‐5p overexpression on the progression and radiosensitivity of EC cells. Moreover, circ‐POSTN acted as a miR‐876‐5p sponge to regulate FYN expression. Circ‐POSTN interference also suppressed tumor growth and enhanced radiosensitivity in vivo.
Conclusion
Circ‐POSTN knockdown inhibited proliferation and invasion, but increased apoptosis and enhanced radiosensitivity in EC cells via modulating miR‐876‐5p/FYN axis, which might be a potential diagnostic and therapeutic target for EC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- Department of Radiation Oncology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
ORCID-Profile: Chen Sun, Mengxi Li, Ruitai Fan
Förderung
- Joint Construction Project of Medical Science and Technology in Henan Province
Zitieren
APA
Chu, A., Sun, C., Liu, Z., Liu, S., Li, M., Song, R., Gan, L., Wang, Y., & Fan, R. (2024). Circ‐POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR ‐876‐5p/ FYN axis. Thoracic Cancer, 15(13), 1082-1094. https://doi.org/10.1111/1759-7714.15273
Vancouver
Chu A, Sun C, Liu Z, Liu S, Li M, Song R, et al. Circ‐POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR ‐876‐5p/ FYN axis. Thoracic Cancer. 2024;15(13):1082-1094. doi:10.1111/1759-7714.15273
BibTeX
@article{Chu2024,
author = {Chu, Alan and Sun, Chen and Liu, Zongwen and Liu, Shijia and Li, Mengxi and Song, Rui and Gan, Lanlan and Wang, Yongtai and Fan, Ruitai},
title = {Circ‐POSTN promotes the progression and reduces radiosensitivity in esophageal cancer by regulating the miR ‐876‐5p/ FYN axis},
journal = {Thoracic Cancer},
year = {2024},
volume = {15},
number = {13},
pages = {1082--1094},
doi = {10.1111/1759-7714.15273}
}
EUVIMED